{
    "nctId": "NCT02000089",
    "briefTitle": "The Cancer of the Pancreas Screening-5 CAPS5)Study",
    "officialTitle": "The Cancer of the Pancreas Screening-5 CAPS5)Study",
    "overallStatus": "RECRUITING",
    "conditions": "Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation, Germline Mutation Carrier, Lynch Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 9000,
    "primaryOutcomeMeasure": "Evaluate pancreatic juice for early cancer markers.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Hereditary Pancreatitis or\n* Peutz-Jeghers Syndrome or\n* Strong family history of pancreas cancer on one side of the family tree or\n* Confirmed germline mutation carrier (BRCA2, FAMMM (CDKN2A/p16), PALB2, BRCA1, ATM, HNPCC, Lynch Syndrome (hMLH1, hMSH2, PMS2, hMSH6, EpCAM) PRSS1, PRSS2, R122H, N291l, SPINK1, CFTR\n* Endoscopic evaluation of pancreas scheduled\n\nExclusion Criteria:\n\n* Medical comorbidities or coagulopathy that contraindicate endoscopy\n* Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis\n* Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope\n* Poor performance status\n* Inability to provide informed consent\n* Pregnancy.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}